BMJ-British Medical Journal

Changes in diversity language in National Institutes of Health grant awards: observational study
Mehta N and Jena AB
To assess changes in the prevalence of diversity language in National Institutes of Health (NIH) grants in 2024-25.
AI chatbots and the loneliness crisis
Shelmerdine SC and Nour MM
Reclaiming human care from surveillance capitalism
Montori V, Montori JP and Montori VM
UK asylum proposals harm health and human rights
Boukari Y, Stevens AJ, Corona S and Devakumar D
Flu: Hospital admissions surge as NHS faces "worst case scenario"
Iacobucci G
Parallel pressures: the common roots of doctor bullshit and large language model hallucinations
Correa Soto RA, McCoy LG, Perdomo-Luna C, Ziegler J, Pino LE, Rico A, Velasco-Muñoz V, Uribe-Castaño A, Rodman A and Celi LA
Spending a penny, pushing up daisies, and other clinical mysteries: an idiomatic journey through the NHS
Polzella P
Why not knowing can be a virtue
Dutta R
An effective public health response to the next pandemic demands learning from past mistakes
Daszkiewicz T
Puberty blockers trial faces potential legal action from campaigners
Dyer C
Correction: Ionising radiation and cardiovascular disease: systematic review and meta-analysis
Antimicrobial use and resistance
Reza N, Dubey V, Sharland M and Hope W
Antimicrobial resistance affects the delivery of safe and effective healthcare. Antimicrobial resistance has attracted strong political focus, with the 2024 United Nations General Assembly high level meeting providing a clear commitment to reducing mortality and improving antibiotic use. This review summarises recent political action, policy prioritisation, and identification of future threats. It considers infections that are caused by drug resistant pathogens and reviews available and new antibiotics that may meet unmet medical needs. Despite increasing political engagement, the global antimicrobial resistance landscape remains imbalanced. In high income hospital settings, diagnostics, antimicrobial stewardship, and infection prevention and control are improving and may be further enabled by artificial intelligence and information systems. The development and use of new antibiotics is a major focus. By contrast, in low and middle income countries, access to most of these advances is limited. In all settings, empirical prescribing of essential antibiotics remains the cornerstone of treatment and conserving their efficacy is critical to effective healthcare. Targeted prevention and optimal treatment strategies are needed to mitigate antimicrobial resistance across all settings.
Masks and flu: What is the debate, and should you wear one?
Iacobucci G
Ministers seek power to control NHS drug approvals to support US pharma deal
Mahase E
Science of longevity medicine
Joshi M, Singh S and Rowley N
UNAIDS: to dissolve or evolve?
Buse K, Sarkar S, Rao JP and Tshabalala S
Migration of clinical lexicon to colloquial slang
Nabavi N
Antidepressant deprescribing: Slow tapering plus therapy is best way to come off medication, say researchers
Wise J
When I use a word . . . Defining bias in research
Aronson JK
Redressing inequities in women's cardiovascular health
Medical training review: a first step towards fixing resident doctor training
Mafi A